Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The demand for COVID-19 detection test kits and consumables has seen remarkable growth over recent years, driven by the urgent need to control and monitor the pandemic. This sector is evolving rapidly, supported by technological advancements and expanding healthcare infrastructure worldwide. Below is a detailed overview of the market’s size, growth factors, segmentation, emerging trends, key players, and regional insights.
COVID-19 Detection Test Kits and Consumables Market Size and Growth Trajectory
The market for COVID-19 detection test kits and consumables demonstrated strong expansion in recent years. It is projected to increase from $8.35 billion in 2025 to $8.94 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This earlier surge was largely due to the initial shortage of test kits, heightened demand from hospitals and public health laboratories, continued reliance on traditional RT-PCR testing methods, limited availability of essential supplies like swabs and reagents, and growing awareness around pandemic surveillance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3255&type=smp
Looking ahead, this market is expected to accelerate further, reaching $13.23 billion by 2030 with a CAGR of 10.3%. The anticipated expansion is driven by advancements in rapid and high-throughput testing kits, increasing numbers of private and commercial laboratories, incorporation of digital reporting systems and cloud-based data management, wider adoption of multiplex and combination test kits, and significant investments in research and diagnostic infrastructure. Key trends shaping the market include rising demand for fast and accurate COVID-19 detection, growth in consumables such as swabs and viral transport media, increasing use of point-of-care and rapid antigen tests, and a stronger emphasis on laboratory standardization and quality compliance.
Government Initiatives Boosting the COVID-19 Detection Test Kits and Consumables Market
Government programs and policies play a crucial role in fostering the growth of the COVID-19 detection test kits and consumables market. Such initiatives provide the necessary framework for effective deployment of testing solutions, supporting public health efforts to manage and reduce the pandemic’s impact. These measures create an enabling environment for widespread access to testing kits and consumables, facilitating timely diagnosis and monitoring.
Access The Complete COVID-19 Detection Test Kits and Consumables Market Report:
For example, in 2025, the American Medical Association reported that health expenditures in the United States increased by 7.5% in 2023, reaching $4.9 trillion or roughly $14,570 per person. This upward trend in healthcare spending underscores the ongoing government commitment and investment in pandemic management, which is a key driver behind the rising demand in the COVID-19 detection test kits and consumables sector.
Detailed Segmentation of the COVID-19 Detection Test Kits and Consumables Market
This market is categorized comprehensively across multiple dimensions:
1) Kits: Including Viral Load Testing Kits (QPCR and RT-PCR), Virus Neutralizing Assay Kits, Antibody Detection Kits (ELISA), Viral Antigen Detection Test Kits, and other types of kits.
2) Consumables: Covering swabs, tubes, viral transport media, reagents, and additional consumable products.
3) Specimen Types: Such as nose and throat swabs, blood samples, sputum, and nasal aspirates.
4) End Uses: Encompassing hospitals, clinics, public health laboratories, private and commercial labs, physician’s offices, research institutes, and other end users.
Subcategories within these segments include specific kit types like QPCR and RT-PCR kits under viral load testing, neutralization test kits in the virus neutralizing assay category, IgG and IgM detection kits under antibody detection, rapid antigen test kits, as well as combination and multiplex test kits.
Innovations and Trends Driving the COVID-19 Detection Market Forward
Key players in the COVID-19 detection test kits and consumables industry are increasingly investing in at-home molecular diagnostic platforms to improve accuracy and convenience for users. Molecular tests detect specific genetic markers such as DNA or RNA from pathogens or biological samples, enabling precise identification of infections.
An example of this trend is the April 2023 launch by Lucira Health, a U.S.-based medical technology company, of its Lucira COVID-19 & Flu Home Test. This product received FDA Emergency Use Authorization (EUA) as the first over-the-counter, at-home combination molecular test for SARS-CoV-2 and influenza A/B. The single-use kit requires a shallow nasal swab that is swirled in a vial and inserted into a battery-operated test unit. Within about 30 minutes, users receive separate results for COVID-19, Flu A, and Flu B, with clinical trial performance comparable to laboratory PCR tests. The test’s key advantages include rapid results, the ability to differentiate flu from COVID-19—both having overlapping symptoms but requiring different treatment—and ease of use at home.
Leading Companies Competing in the COVID-19 Detection Test Kits and Consumables Market
Several prominent companies are shaping this market through innovation and extensive product portfolios. These include Cepheid, BGI Genomics, Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche, GenMark Diagnostics, Mylab Discovery Solutions, Qiagen, Quidel Corporation, Randox Laboratories, SD Biosensor, Seegene Inc., Shenzhen Bioeasy Biotechnology, Thermo Fisher Scientific Inc., BioMedomics, Getein Biotech, Sensing Self Ltd., Hangzhou Biotest Biotech Co. Ltd, AmonMed Biotechnology Co., Beijing Tigsun Diagnostics Co. Ltd., BioMaxima S.A., CTK Biotech, Hunan Lituo Biotechnology Co., Vivacheck Lab, MD Solutions, FastSense Diagnostics, Altona Diagnostics, Siemens AG, Agilent Technologies Inc., Seasun Biomaterials, BTNX Inc., Rapiim, Canon Medical Systems Corporation, Cellspect Co. Ltd., iHealth Labs Inc., InBios International Inc., iXensor Co. Ltd., Jiangsu Medomics Medical Technology Co. Ltd., Maxim Biomedical Inc., Mologic Inc., OraSure Technologies Inc., OSANG LLC, PHASE Scientific International Ltd., Watmind USA, and Xiamen Boson Biotech Co. Ltd.
Regional Overview Highlighting Market Leaders in COVID-19 Detection
In 2025, North America emerged as the largest market for COVID-19 detection test kits and consumables. The market report also covers other significant regions including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on the market’s growth patterns and regional dynamics.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
